Antiplatelet therapy of patients with intracranial aneurysms undergoing stent-assisted coil embolization

杜洪福,李一辰,徐曼曼,刘涛,伊曼曼,葛卫红,于锋
DOI: https://doi.org/10.3760/cma.j.issn.1673-4165.2022.03.012
2022-01-01
Abstract:Stent-assisted coil embolization is a common endovascular treatment for ruptured/unruptured intracranial aneurysms. Stent implantation process can damage vascular endothelium, activate platelet and coagulation cascade, and then increase the risk of thrombosis. In order to reduce the risk of postoperative embolism, antiplatelet therapy is required. Among them, aspirin combined with clopidogrel dual antiplatelet therapy is a commonly used strategy. For patients with low response to clopidogrel, tigrelol or cilostazol can be used as an alternative drug. Although the scheme has been considered to be effective and safe, it is still controversial.
What problem does this paper attempt to address?